The first five years of a child's life are crucial when it comes to preventing obesity in the future, according to researchers.Experts in the Netherlands found body mass index (BMI) at age six is a ...

Semaglutide can rapidly reduce heart attacks and other serious cardiovascular complications in adults with overweight or ...

Tirzepatide conferred significantly greater weight loss than semaglutide at 72 weeks for adults with overweight or obesity, ...

New research being presented at the European Congress on Obesity (ECO 2025) has found that patients of an online obesity ...

Reducing exposure to medicines is always a good thing if similar clinical outcomes can be achieved, and the study suggests it ...

Weight-loss injections, or GLP-1 receptor agonists, could nearly halve the risk of obesity-related cancers, a new study finds ...

What if your toddler's chubby belly wasn't just "baby fat" that would disappear, but an early warning sign for serious health ...

A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...

For the 2025 outlook, Novo Nordisk now expects 13-21% revenue increase at constant exchange rates (CER). Operating profit is ...

At the core of the “Make America Healthy Again” movement is a fatal contradiction. On the surface, it purports to favor the ...

Obesity before 30 almost doubles risk of dying young - Experts stressed the study was a ‘wake-up call’ that obesity can ...

The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published ...